Developer docs
API playgroundTry for free, no card

Search company profiles

Mindset Health

Full company profile

uuid0000ozo

Namestring
Mindset Health
Legal namestring
Mindset Health Pty Ltd
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Mindset Health is an Australian-headquartered digital therapeutics company that develops AI-powered, app-delivered hypnotherapy and brain-body behavioral programs for chronic conditions where pharmacology underperforms. The company's portfolio comprises four commercial programs — Nerva for IBS and functional dyspepsia (built with Dr. Simone Peters at Monash University), Evia for menopausal hot flashes (built with Dr. Gary Elkins at Baylor), Claria for anxiety, depression, and stress (developed with Dr. Michael Yapko), and Relio for chronic primary pain (developed with NeuRA) — each delivered via iOS and Android apps in 70+ countries to 350,000+ patients. The platform applies AI to personalize content sequencing and audio delivery based on symptom tracking, preferences, and engagement patterns, while the underlying clinical protocols are pre-authored by named academic founders and validated in peer-reviewed randomized controlled trials, including an AJG 2025 RCT (n=244) demonstrating efficacy against an active control for IBS.

The business operates a hybrid go-to-market model. Consumer revenue comes from annual subscriptions purchased via the App Store, Google Play, and program-specific websites, with a 25% automatic discount for practitioner-referred patients. Enterprise revenue comes from outcome-aligned contracts with US health plans and payers, structured around pre-agreed symptom-reduction thresholds with symmetric risk, modeled at $500 per enrolled member per year with a 5.2x gross-to-cost ratio, and deployed to 136,000+ US members through commercial, Medicare Advantage, and ASO books. The company was selected for the CMS ACCESS Model in 2026 for MSK and behavioral health tracks. A referring-provider channel of 20,000+ clinicians globally (8,700+ in the US) drives bottom-up clinical adoption via EHR order sets, e-referral, and secure web forms, with patient-reported outcome measures fed back to clinicians at weeks 6, 12, and 24. Mindset Health is HIPAA- and SOC 2 Type II-compliant, operates from Melbourne (HQ) and New York (US commercial office), and has raised approximately $19.65M across four disclosed funding rounds including a $12M Series A in March 2023 led by King River Capital.

Short descriptiontext

Mindset Health develops AI-personalized, app-delivered hypnotherapy and brain-body programs for chronic IBS, menopause, anxiety, and pain conditions. It sells annual consumer subscriptions and outcome-aligned contracts to US health plans, serving 350,000+ patients across 70+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital therapeutics, hypnotherapy apps, gut-directed hypnotherapy, brain-body behavioral programs, chronic condition management
Industry4 codes
1Behavioral Health & Neurocognitive Therapeutics (Digital)
CodeHLACANAIPrimaryYes
2General Mental Health Therapy Platforms (Talk Therapy)
CodeHLALAEAAPrimaryNo
3Meditation Apps, Digital Courses & Online Communities
CodeHSADAJAHPrimaryNo
4Healthcare & Wellness Personalization
CodeHDAAAGAIPrimaryNo
NAICS code2 codes
  • Offices of Mental Health Practitioners (except Physicians)621330
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Digital Therapeutics
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model2 records
1Annual Program Subscription
TypeSubscription Recurring
Description

Each program is offered as an annual subscription. Individual consumers purchase direct. Practitioner-referred patients receive an automatic 25% discount. Health plan and employer coverage is contracted separately. Comparable in cost to a single specialist session. Patient Assistance Program available for those facing financial hardship.

mindsethealth.com
2Health Plan and Payer Contracts
TypeSubscription Recurring
Description

Outcome-aligned commercial contracts with health plans and payers tied to pre-agreed symptom-reduction thresholds. Symmetric risk structure with withholding on the company side. CMS ACCESS-aligned contracts for Medicare and commercial books. Program cost modeled at $500/year per enrolled member with estimated gross-to-cost ratio of 5.2x.

mindsethealth.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Annual subscription per program with 25% practitioner referral discount
ModelSubscriptionBilling cadenceAnnual
Notes

Annual subscription. Practitioner-referred patients receive 25% off automatically. Comparable to a single specialist session. Patient Assistance Program available for financial hardship cases. Health plan/employer coverage contracted separately.

mindsethealth.com
2Health plan / employer outcome-aligned contract
ModelOutcome Based/ PerformanceBilling cadenceAnnual
Notes

Outcome-aligned contracts with pre-agreed symptom tracking thresholds. Symmetric risk structure. CMS ACCESS-aligned. Program cost modeled at $500/year per enrolled member with estimated ROI of 5.2x. Gross-to-cost ratio of 5.2x modeled by PHTI 2026.

mindsethealth.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 4 records shown
1Nerva
Description

A six-week gut-brain behavioral program for people with IBS. Built with Dr Simone Peters from Monash University, it delivers gut-directed hypnotherapy via a mobile app.

mindsethealth.com
+3 more records
Core offering1 text field

Mindset Health sells AI-powered mobile-app digital therapeutics that deliver clinically validated brain-body behavioral programs — primarily gut-directed hypnotherapy and related techniques — for chronic conditions including IBS, menopause symptoms, chronic primary pain, and anxiety/depression. Each program runs over 5-6 weeks with daily audio sessions, lessons, and exercises that AI-personalizes to the user's symptoms, progress, and engagement, and is sold either as an annual consumer subscription or via outcome-aligned contracts to health plans, payers, and employers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 81% of participants met IBS-SSS responder threshold at 6 weeks, vs. 63% on active control (AJG 2025, n=244)
+6 more records
Product overview1 text field

Mindset Health is a digital therapeutics company offering AI-powered brain-body behavioral programs delivered through mobile apps. The portfolio consists of four distinct commercial products: Nerva (gut/brain program for IBS and functional dyspepsia), Evia (menopause program for vasomotor symptoms), Claria (mental health program for anxiety, depression, and stress), and Relio (pain program for chronic primary pain). All programs share the same underlying therapeutic model—digitally delivered hypnotherapy and brain-body techniques—which adapts to each user's symptoms, goals, and progress. Programs are built with academic partners (Monash University, Baylor University, NeuRA) on protocols validated in peer-reviewed randomized controlled trials and delivered via subscription mobile apps.

Product and service4 records
1Nerva
CategoryDigital therapeutic — gastrointestinal (IBS / functional dyspepsia)
Description

A six-week AI-personalized gut-brain behavioral program delivered via mobile app for adults with IBS and functional dyspepsia, delivering gut-directed hypnotherapy with guided mental imagery, psychoeducation, and adherence support to recalibrate the brain-gut axis. Validated in the AJG 2025 RCT (n=244) against an active control.

2Evia
CategoryDigital therapeutic — menopause / vasomotor symptoms
Description

A five-week non-hormonal, AI-personalized digital program for hot flashes, night sweats, and broken sleep associated with menopause, designed for women who cannot or prefer not to use hormone therapy (including breast cancer patients). 76% of participants reported ≥50% reduction in daily hot flashes in a real-world cohort (Scheffrahn, JMIR 2025, n=139).

3Claria
CategoryDigital therapeutic — mental health (anxiety, depression, stress)
Description

Short, daily AI-personalized sessions delivered via mobile app that help adults manage the autonomic and cognitive patterns behind anxiety, depression, and everyday stress. Developed with Dr Michael Yapko using his autonomic and cognitive regulation approach to clinical hypnosis.

4Relio
CategoryDigital therapeutic — chronic primary pain
Description

A six-week AI-personalized pain reprocessing program for chronic primary pain (including chronic back pain and fibromyalgia) where structural disease has been ruled out or stabilized, helping patients reinterpret persistent pain signals as safe rather than threatening. Developed with NeuRA.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Mindset Health collaborates with Monash University on research and protocol development. Dr Simone Peters, a Monash University researcher and founder of the Mind + Gut Clinic, developed the gut-directed hypnotherapy protocol that became Nerva. Research collaboration includes a founding-protocol RCT (Peters 2016, Alimentary Pharmacology & Therapeutics) and ongoing DGBI expansion research. Monash University is a key research partner shown in logos across the website.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr Gary Elkins, Professor of Psychology and Neuroscience at Baylor University and director of the Mind-Body Medicine Research Laboratory, is the content founder for Evia (menopause program) and Finito. He is the senior author of foundational hypnosis trials for menopausal hot flashes, including a 2013 RCT in Menopause. The company cites this collaboration as the basis for the Evia menopause program.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Massachusetts General Hospital is listed as a research partner on the Mindset Health website. Dr Kyle Staller, Director of the GI Motility Laboratory at Mass General and Associate Professor of Medicine at Harvard Medical School, serves on the Clinical Advisory Board.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Mayo Clinic is listed as a research partner on the Mindset Health website, alongside other leading academic medical centers (Monash, Mass General, Mount Sinai, NeuRA).

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Mount Sinai is listed as a research partner on the Mindset Health website, alongside other leading academic medical centers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NeuRA collaborated with Mindset Health on the development of Relio, a six-week pain reprocessing program for chronic primary pain. NeuRA is an Australian neuroscience research institute and a key partner in the pain program. Listed as a research partner across the website.

7Dr Michael Yapko
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr Michael Yapko, a clinical psychologist known for pioneering strategic, outcome-focused psychotherapies and advanced clinical hypnosis, is the content founder for Claria (mental health program). He has authored more than a dozen books and is a worldwide lecturer. Dr Yapko developed the autonomic and cognitive regulation approach used in Claria.

mindsethealth.com
Strategic tierSupportingTypeGTM or Marketing Partner
Description

HIF Health Insurance partnered with Mindset Health to provide digital hypnotherapy programs to their insured members. This partnership was noted in a market overview of the U.S. Complementary and Alternative Medicine market as a key recent development, expanding access to Mindset's digital therapeutic programs through a health insurance channel.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Alfred Health in Melbourne is affiliated with Dr Simone Peters' research and the gut-directed hypnotherapy protocol development. Dr Peters conducts research with both Alfred Health and Monash University. The protocol developed at these institutions became the basis for Nerva.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Digital MSK and chronic pain platform with employer/payer distribution. Comparable in chronic pain to Relio and in self-guided mobile delivery model to Mindset Health's broader portfolio.

TypeDirect peer
Description

Digital therapeutics company (EndeavorRx, etc.) delivering FDA-cleared software-based cognitive therapeutics. Closely comparable as a prescription digital therapeutic pursuing payer coverage with evidence-based outcomes, though focused on cognition rather than brain-body behavioral therapy.

TypeEmerging player
Description

Consumer meditation and sleep app with growing enterprise/B2B distribution. Adjacent to Claria in stress and sleep; comparable in mobile subscription model and consumer self-enrollment motion, though positioned as wellness rather than digital therapeutic.

TypeBroad incumbent
Description

Digital MSK and pelvic health platform with AI-powered programs. Competes with Relio on chronic pain and was also selected for CMS ACCESS in MSK, making it a direct comparator in the enterprise and federal outcome-aligned contracting landscape.

TypeDirect peer
Description

Digital therapeutics company focused on gut-brain conditions including IBS. Competes head-to-head with Mindset Health in digital gut-directed hypnotherapy and shares the same regulatory and payer-contract pathway.

TypeBroad incumbent
Description

Largest digital MSK and pain player with deep employer and payer contracts. Comparable to Mindset's Relio program in chronic pain; selected by CMS for ACCESS in MSK alongside Mindset, making it a direct competitor in the same federally-aligned outcome-paid channel.

TypeDirect peer
Description

Direct competitor in digital therapeutics for IBS. Mahana's product (Regulora/H家的) targets the same gut-directed hypnotherapy indication as Nerva with a similar mobile-delivered model, making it the closest functional competitor in the IBS DTx category.

TypeDirect peer
Description

Digital therapeutics company (Sleepio for insomnia, Daylight for anxiety) delivering automated cognitive behavioral therapy via mobile apps. Closely comparable in business model, evidence standards, payer contracting, and chronic-condition focus.

TypeDirect peer
Description

Digital therapeutic platform for digestive conditions including IBS. Competes with Nerva in the same indication through a mobile-app delivery model combining behavioral therapy, education, and tracking — same patient population and provider channel.

TypeBroad incumbent
Description

Mental wellness platform combining meditation, mindfulness, and therapy (Ginger). Overlaps with Claria on anxiety, depression, and stress; comparable in B2B employer/payer distribution and consumer app-store delivery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors15 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mindset Health

Digital Therapeuticsmindsethealth.com

Mindset Health develops AI-personalized, app-delivered hypnotherapy and brain-body programs for chronic IBS, menopause, anxiety, and pain conditions. It sells annual consumer subscriptions and outcome-aligned contracts to US health plans, serving 350,000+ patients across 70+ countries.

What Mindset Health does

Mindset Health is an Australian-headquartered digital therapeutics company that develops AI-powered, app-delivered hypnotherapy and brain-body behavioral programs for chronic conditions where pharmacology underperforms. The company's portfolio comprises four commercial programs — Nerva for IBS and functional dyspepsia (built with Dr. Simone Peters at Monash University), Evia for menopausal hot flashes (built with Dr. Gary Elkins at Baylor), Claria for anxiety, depression, and stress (developed with Dr. Michael Yapko), and Relio for chronic primary pain (developed with NeuRA) — each delivered via iOS and Android apps in 70+ countries to 350,000+ patients. The platform applies AI to personalize content sequencing and audio delivery based on symptom tracking, preferences, and engagement patterns, while the underlying clinical protocols are pre-authored by named academic founders and validated in peer-reviewed randomized controlled trials, including an AJG 2025 RCT (n=244) demonstrating efficacy against an active control for IBS.

The business operates a hybrid go-to-market model. Consumer revenue comes from annual subscriptions purchased via the App Store, Google Play, and program-specific websites, with a 25% automatic discount for practitioner-referred patients. Enterprise revenue comes from outcome-aligned contracts with US health plans and payers, structured around pre-agreed symptom-reduction thresholds with symmetric risk, modeled at $500 per enrolled member per year with a 5.2x gross-to-cost ratio, and deployed to 136,000+ US members through commercial, Medicare Advantage, and ASO books. The company was selected for the CMS ACCESS Model in 2026 for MSK and behavioral health tracks. A referring-provider channel of 20,000+ clinicians globally (8,700+ in the US) drives bottom-up clinical adoption via EHR order sets, e-referral, and secure web forms, with patient-reported outcome measures fed back to clinicians at weeks 6, 12, and 24. Mindset Health is HIPAA- and SOC 2 Type II-compliant, operates from Melbourne (HQ) and New York (US commercial office), and has raised approximately $19.65M across four disclosed funding rounds including a $12M Series A in March 2023 led by King River Capital.

Mindset Health firmographics

Firmographics
Name
Mindset Health
Legal name
Mindset Health Pty Ltd
Website
https://mindsethealth.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Mindset Health develops AI-personalized, app-delivered hypnotherapy and brain-body programs for chronic IBS, menopause, anxiety, and pain conditions. It sells annual consumer subscriptions and outcome-aligned contracts to US health plans, serving 350,000+ patients across 70+ countries.
Ownership category
akta.pro rank

Mindset Health industry classification

Industry
Product category
Digital Therapeutics
NAICS
Offices of Mental Health Practitioners (except Physicians) (621330), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro primary industry
Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
akta.pro secondary industries
General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA), Meditation Apps, Digital Courses & Online Communities (HSADAJAH), Healthcare & Wellness Personalization (HDAAAGAI)

Keywords

  • Digital therapeutics
  • Hypnotherapy apps
  • Gut-directed hypnotherapy
  • Brain-body behavioral programs
  • Chronic condition management

Where Mindset Health is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Mindset Health business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Annual Program Subscription: Each program is offered as an annual subscription. Individual consumers purchase direct. Practitioner-referred patients receive an automatic 25% discount. Health plan and employer coverage is contracted separately. Comparable in cost to a single specialist session. Patient Assistance Program available for those facing financial hardship.
  2. Health Plan and Payer Contracts: Outcome-aligned commercial contracts with health plans and payers tied to pre-agreed symptom-reduction thresholds. Symmetric risk structure with withholding on the company side. CMS ACCESS-aligned contracts for Medicare and commercial books. Program cost modeled at $500/year per enrolled member with estimated gross-to-cost ratio of 5.2x.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualAnnual subscription per program with 25% practitioner referral discount
Outcome Based/ PerformanceAnnualHealth plan / employer outcome-aligned contract

Go-to-market motion4 records

Distribution channels5 records

Marketing channels7 records

Mindset Health product offering

Product offering

Core offering

Mindset Health sells AI-powered mobile-app digital therapeutics that deliver clinically validated brain-body behavioral programs — primarily gut-directed hypnotherapy and related techniques — for chronic conditions including IBS, menopause symptoms, chronic primary pain, and anxiety/depression. Each program runs over 5-6 weeks with daily audio sessions, lessons, and exercises that AI-personalizes to the user's symptoms, progress, and engagement, and is sold either as an annual consumer subscription or via outcome-aligned contracts to health plans, payers, and employers.

Product overview

Mindset Health is a digital therapeutics company offering AI-powered brain-body behavioral programs delivered through mobile apps. The portfolio consists of four distinct commercial products: Nerva (gut/brain program for IBS and functional dyspepsia), Evia (menopause program for vasomotor symptoms), Claria (mental health program for anxiety, depression, and stress), and Relio (pain program for chronic primary pain). All programs share the same underlying therapeutic model—digitally delivered hypnotherapy and brain-body techniques—which adapts to each user's symptoms, goals, and progress. Programs are built with academic partners (Monash University, Baylor University, NeuRA) on protocols validated in peer-reviewed randomized controlled trials and delivered via subscription mobile apps.

Differentiator

Problem solved

Functional benefit

Brands

  • Nerva: A six-week gut-brain behavioral program for people with IBS. Built with Dr Simone Peters from Monash University, it delivers gut-directed hypnotherapy via a mobile app.
  • Evia
  • Claria
  • Relio

Products and services

  • Nerva A six-week AI-personalized gut-brain behavioral program delivered via mobile app for adults with IBS and functional dyspepsia, delivering gut-directed hypnotherapy with guided mental imagery, psychoeducation, and adherence support to recalibrate the brain-gut axis. Validated in the AJG 2025 RCT (n=244) against an active control.
  • Evia A five-week non-hormonal, AI-personalized digital program for hot flashes, night sweats, and broken sleep associated with menopause, designed for women who cannot or prefer not to use hormone therapy (including breast cancer patients). 76% of participants reported ≥50% reduction in daily hot flashes in a real-world cohort (Scheffrahn, JMIR 2025, n=139).
  • Claria Short, daily AI-personalized sessions delivered via mobile app that help adults manage the autonomic and cognitive patterns behind anxiety, depression, and everyday stress. Developed with Dr Michael Yapko using his autonomic and cognitive regulation approach to clinical hypnosis.
  • Relio A six-week AI-personalized pain reprocessing program for chronic primary pain (including chronic back pain and fibromyalgia) where structural disease has been ruled out or stabilized, helping patients reinterpret persistent pain signals as safe rather than threatening. Developed with NeuRA.

Quantifiable outcome

  • 81% of participants met IBS-SSS responder threshold at 6 weeks, vs. 63% on active control (AJG 2025, n=244)
  • +6 more outcomes

Companies that use Mindset Health

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Mindset Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature5 records

Mindset Health partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and supporting.

  • Monash UniversitycoreStrategic or Co-development PartnerMindset Health collaborates with Monash University on research and protocol development. Dr Simone Peters, a Monash University researcher and founder of the Mind + Gut Clinic, developed the gut-directed hypnotherapy protocol that became Nerva. Research collaboration includes a founding-protocol RCT (Peters 2016, Alimentary Pharmacology & Therapeutics) and ongoing DGBI expansion research. Monash University is a key research partner shown in logos across the website.
  • Baylor UniversitycoreStrategic or Co-development PartnerDr Gary Elkins, Professor of Psychology and Neuroscience at Baylor University and director of the Mind-Body Medicine Research Laboratory, is the content founder for Evia (menopause program) and Finito. He is the senior author of foundational hypnosis trials for menopausal hot flashes, including a 2013 RCT in Menopause. The company cites this collaboration as the basis for the Evia menopause program.
  • Massachusetts General HospitalsupportingStrategic or Co-development PartnerMassachusetts General Hospital is listed as a research partner on the Mindset Health website. Dr Kyle Staller, Director of the GI Motility Laboratory at Mass General and Associate Professor of Medicine at Harvard Medical School, serves on the Clinical Advisory Board.
  • Mayo ClinicsupportingStrategic or Co-development PartnerMayo Clinic is listed as a research partner on the Mindset Health website, alongside other leading academic medical centers (Monash, Mass General, Mount Sinai, NeuRA).
  • Mount SinaisupportingStrategic or Co-development PartnerMount Sinai is listed as a research partner on the Mindset Health website, alongside other leading academic medical centers.
  • NeuRA (Neuroscience Research Australia)coreStrategic or Co-development PartnerNeuRA collaborated with Mindset Health on the development of Relio, a six-week pain reprocessing program for chronic primary pain. NeuRA is an Australian neuroscience research institute and a key partner in the pain program. Listed as a research partner across the website.
  • Dr Michael YapkocoreStrategic or Co-development PartnerDr Michael Yapko, a clinical psychologist known for pioneering strategic, outcome-focused psychotherapies and advanced clinical hypnosis, is the content founder for Claria (mental health program). He has authored more than a dozen books and is a worldwide lecturer. Dr Yapko developed the autonomic and cognitive regulation approach used in Claria.
  • HIF Health InsurancesupportingGTM or Marketing PartnerHIF Health Insurance partnered with Mindset Health to provide digital hypnotherapy programs to their insured members. This partnership was noted in a market overview of the U.S. Complementary and Alternative Medicine market as a key recent development, expanding access to Mindset's digital therapeutic programs through a health insurance channel.
  • Alfred HealthsupportingStrategic or Co-development PartnerAlfred Health in Melbourne is affiliated with Dr Simone Peters' research and the gut-directed hypnotherapy protocol development. Dr Peters conducts research with both Alfred Health and Monash University. The protocol developed at these institutions became the basis for Nerva.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Mindset Health competitors and assessment

Company assessment

Broad incumbents

  • Kaia Health: Digital MSK and chronic pain platform with employer/payer distribution. Comparable in chronic pain to Relio and in self-guided mobile delivery model to Mindset Health's broader portfolio.
  • Sword Health: Digital MSK and pelvic health platform with AI-powered programs. Competes with Relio on chronic pain and was also selected for CMS ACCESS in MSK, making it a direct comparator in the enterprise and federal outcome-aligned contracting landscape.
  • Hinge Health: Largest digital MSK and pain player with deep employer and payer contracts. Comparable to Mindset's Relio program in chronic pain; selected by CMS for ACCESS in MSK alongside Mindset, making it a direct competitor in the same federally-aligned outcome-paid channel.
  • Headspace Health: Mental wellness platform combining meditation, mindfulness, and therapy (Ginger). Overlaps with Claria on anxiety, depression, and stress; comparable in B2B employer/payer distribution and consumer app-store delivery.

Direct peers

  • Akili Interactive: Digital therapeutics company (EndeavorRx, etc.) delivering FDA-cleared software-based cognitive therapeutics. Closely comparable as a prescription digital therapeutic pursuing payer coverage with evidence-based outcomes, though focused on cognition rather than brain-body behavioral therapy.
  • metaMe Health: Digital therapeutics company focused on gut-brain conditions including IBS. Competes head-to-head with Mindset Health in digital gut-directed hypnotherapy and shares the same regulatory and payer-contract pathway.
  • Mahana Therapeutics: Direct competitor in digital therapeutics for IBS. Mahana's product (Regulora/H家的) targets the same gut-directed hypnotherapy indication as Nerva with a similar mobile-delivered model, making it the closest functional competitor in the IBS DTx category.
  • Big Health: Digital therapeutics company (Sleepio for insomnia, Daylight for anxiety) delivering automated cognitive behavioral therapy via mobile apps. Closely comparable in business model, evidence standards, payer contracting, and chronic-condition focus.
  • Bold Health (Cara Care): Digital therapeutic platform for digestive conditions including IBS. Competes with Nerva in the same indication through a mobile-app delivery model combining behavioral therapy, education, and tracking — same patient population and provider channel.

Emerging players

  • Calm: Consumer meditation and sleep app with growing enterprise/B2B distribution. Adjacent to Claria in stress and sleep; comparable in mobile subscription model and consumer self-enrollment motion, though positioned as wellness rather than digital therapeutic.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Mindset Health social profiles

Digital presence

Mindset Health compliance and trust

Trust signal

Compliance2 records

Mindset Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mindset Health leadership team

Management profile

Number of profiles

Profiles3 records

Mindset Health funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mindset Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mindset Health

What does Mindset Health do?

Mindset Health sells AI-powered mobile-app digital therapeutics that deliver clinically validated brain-body behavioral programs — primarily gut-directed hypnotherapy and related techniques — for chronic conditions including IBS, menopause symptoms, chronic primary pain, and anxiety/depression. Each program runs over 5-6 weeks with daily audio sessions, lessons, and exercises that AI-personalizes to the user's symptoms, progress, and engagement, and is sold either as an annual consumer subscription or via outcome-aligned contracts to health plans, payers, and employers.

Is Mindset Health a public or private company?

Mindset Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Mindset Health founded?

Mindset Health was founded in 2019. It employs 11 to 50 people.

Where is Mindset Health based?

Mindset Health is headquartered in Melbourne, Australia, in the Oceania region.

How does Mindset Health make money?

Two revenue lines are on record. Annual Program Subscription is the primary driver. The others are health Plan and Payer Contracts.

Who are Mindset Health's main competitors?

Broad incumbents on record are Kaia Health, Sword Health, Hinge Health and Headspace Health. Direct peers are Akili Interactive, metaMe Health, Mahana Therapeutics, Big Health and Bold Health (Cara Care). Calm is listed as an emerging player.

Does Mindset Health have an API?

No public API is recorded for Mindset Health.

What industry is Mindset Health in?

Mindset Health's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy). Its NAICS code is 621330 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireEligible Original Medicare patients can now access Nerva's gut-brain therapy program at no out-of-pocket costEligible US patients with Original Medicare can now access Nerva, the gut-brain therapy program for IBS and other gut-brain disorders, at no out-of-pocket cost through the CMS ACCESS Model. Mindset Health, the company behind Nerva, began participating in this CMS Innovation Center payment model on July 5, 2026. The ACCESS Model rewards programs based on patient outcomes rather than per-visit fees and is designed for evidence-based, technology-supported chronic care programs.Market ScoopU.S. Complementary and Alternative Medicine MarketThe U.S. Complementary and Alternative Medicine market is projected to grow from US$ 53.1 billion in 2025 to US$ 656.9 billion by 2035, representing a compound annual growth rate of 28.6%, driven by rising consumer adoption of non-conventional therapies for pain management and holistic wellness. Recent market developments include Magstim's FDA clearance for transcranial magnetic stimulation systems for adolescent depression, Soaak Technologies' acquisition of Tulsa Natural Health Clinic, HIF Health Insurance's partnership with Mindset Health for digital hypnotherapy programs, and Nordic Naturals' nationwide omega-3 awareness campaign alongside expanded Sam's Club distribution. Key growth constraints remain, including limited insurance reimbursement for many complementary therapies, while opportunities lie in deeper integration of these approaches into mainstream healthcare settings.Monash UniversityCan Tech Unlock Humans’ Full Potential? – Monash UniversityMonash University's podcast 'What Happens Next?' released its final episode on transhumanism, featuring experts from Mindset Health and EMOTIV discussing the integration of technology with human biology. The discussion highlighted advancements in brain-computer interfaces, neurotechnology, and artificial organs like ventricular assist devices as pathways to enhancing human capabilities. Participants emphasized the need for inclusive societal frameworks and regulatory oversight to ensure these emerging technologies benefit humanity equitably.MedtechalertMindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale DistributionMindset Health secured a $12 million Series A funding round led by King River Capital to expand its digital hypnotherapy applications and scale distribution globally. The company plans to use the capital to develop new apps for conditions such as anxiety, depression, sleep issues, and chronic pain while enhancing existing clinical research partnerships with institutions like Baylor University and Monash University. This investment supports the growth of Mindset Health's current portfolio addressing irritable bowel syndrome, menopause, and smoking cessation across key markets including the US, Australia, and the UK.PR NewswireMindset Health raises US$12m to expand digital hypnotherapy apps & scale distributionMindset Health announced the raising of US$12 million in an oversubscribed Series A financing round led by King River Capital to expand its digital hypnotherapy applications. The funds will be used to broaden distribution channels, launch new apps for conditions such as anxiety and depression, and support clinical research partnerships with institutions like Baylor University and Monash University. This investment supports the company's strategy to scale its evidence-based health solutions globally, particularly in its top markets of the United States, Australia, and the United Kingdom.MindsethealthMelbourne brothers build a $77m business from hypnotherapy appsMindset Health, a Melbourne-based medical technology startup founded by brothers Alex and Chris Naoumidis, has raised $17.8 million in a Series A funding round led by King River Capital, achieving a post-money valuation of $52 million. The company utilizes hypnotherapy apps to manage conditions such as irritable bowel syndrome, menopausal hot flushes, and smoking cessation, currently serving 31,000 paid monthly subscribers with approximately 38% based in the US. The fresh capital will be used to expand its team and develop new applications for anxiety, depression, sleep, and chronic pain while supporting ongoing clinical research.PR NewswireGI OnDEMAND Partnership with Mindset Health/Nerva Makes It Easy for Gastroenterology Practices Nationwide to Deliver Gut-Directed Hypnotherapy to Their IBS PatientsGI OnDEMAND, gastroenterology's multidisciplinary virtual care platform, announced a partnership with Mindset Health to deliver Nerva's gut-directed hypnotherapy mobile app to IBS patients nationwide. The program addresses longstanding barriers to evidence-based care, including limited access to GI psychologists, long waitlists, and high therapy costs. This partnership enables GI practices to offer patients a clinically-proven digital therapeutic option for managing irritable bowel syndrome symptoms.SmartCompanyMindset Health secures $6.7 million for tech bringing hypnosis into healthcareMelbourne-based digital hypnotherapy startup Mindset Health has secured US$5 million (AUD $6.7 million) in funding to scale its technology for treating conditions such as IBS and menopause. The company, founded by brothers Chris and Alex Naoumidis, is expanding its portfolio of hypnosis-based digital therapeutic apps.TechCrunchHypnosis for health? Investors have placed a $1.1 million bet on Mindset Health that it can workAustralian brothers Chris and Alex Naoumidis founded Mindset Health, a hypnotherapy app startup, after experiencing the benefits of hypnotherapy themselves, and closed a $1.1 million funding round in November 2019 with investors including Fifty Years, YC, Gelt VC, Giant Leap VC, and angel investors across the U.S. and Australia. The company has developed Nerva, an IBS-focused subscription app priced at $99 upfront plus $88 for three months, alongside a general mental wellness Mindset toolkit, and reports that 90% of users who complete its programs self-report reduced symptoms. Mindset Health aims to digitize clinically developed hypnotherapy programs to make them more widely accessible, positioning itself within the growing mental health app market alongside competitors like Calm and Headspace.